Invention Grant
US08436180B2 Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
有权
取代的4-芳基-1,4-二氢-1,6-萘啶酰胺及其用途
- Patent Title: Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
- Patent Title (中): 取代的4-芳基-1,4-二氢-1,6-萘啶酰胺及其用途
-
Application No.: US12526951Application Date: 2008-02-19
-
Publication No.: US08436180B2Publication Date: 2013-05-07
- Inventor: Lars Bärfacker , Peter Kolkhof , Karl-Heinz Schlemmer , Rolf Grosser , Adam Nitsche , Martina Klein , Klaus Münter , Barbara Albrecht-Küpper , Elke Hartmann
- Applicant: Lars Bärfacker , Peter Kolkhof , Karl-Heinz Schlemmer , Rolf Grosser , Adam Nitsche , Martina Klein , Klaus Münter , Barbara Albrecht-Küpper , Elke Hartmann
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Agent Karen B. King
- Priority: DE102007009494 20070227
- International Application: PCT/EP2008/001257 WO 20080219
- International Announcement: WO2008/104306 WO 20080904
- Main IPC: C07D471/02
- IPC: C07D471/02 ; A61K31/44
Abstract:
The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridine-3-carboxamides, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.
Public/Granted literature
- US20100136142A1 SUBSTITUTED-4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINAMIDES AND USE THEREOF Public/Granted day:2010-06-03
Information query
